Literature DB >> 8386897

Strong immunoreactivity of alpha 1-antichymotrypsin co-localizes with beta-amyloid protein and ubiquitin in vacuolated muscle fibers of inclusion-body myositis.

M Bilak1, V Askanas, W K Engel.   

Abstract

In 10 of 10 inclusion-body myositis (IBM) patients, including 1 hereditary case, vacuolated muscle fibers contained large or small cytoplasmic inclusions immunoreactive for alpha 1-antichymotrypsin (alpha 1-ACT). All IBM muscle biopsies had characteristic cytoplasmic tubulo-filaments by electron microscopy. None of 17 control muscle biopsies contained the alpha 1-ACT immunoreactive inclusions characteristic of IBM. In vacuolated muscle fibers, alpha 1-ACT immunoreactive inclusions colocalized with beta-amyloid protein and ubiquitin immunoreactivities. Our study provides the first demonstration of alpha 1-ACT accumulations in abnormal human muscle, and it suggest that, as in Alzheimer's disease and Down's syndrome, alpha 1-ACT may be involved in the pathogenesis of IBM.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386897     DOI: 10.1007/bf00334447

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  33 in total

1.  Immunocytochemical localization of ubiquitin at human neuromuscular junctions.

Authors:  P Serdaroglu; V Askanas; W K Engel
Journal:  Neuropathol Appl Neurobiol       Date:  1992-06       Impact factor: 8.090

2.  Familial inclusion body myositis: evidence for autosomal dominant inheritance.

Authors:  H E Neville; L L Baumbach; S P Ringel; L S Russo; E Sujansky; C A Garcia
Journal:  Neurology       Date:  1992-04       Impact factor: 9.910

Review 3.  Polymyositis, dermatomyositis and inclusion-body myositis.

Authors:  M C Dalakas
Journal:  N Engl J Med       Date:  1991-11-21       Impact factor: 91.245

4.  Alpha 1-antichymotrypsin is associated solely with amyloid deposits containing the beta-protein. Amyloid and cell localization of alpha 1-antichymotrypsin.

Authors:  C R Abraham; T Shirahama; H Potter
Journal:  Neurobiol Aging       Date:  1990 Mar-Apr       Impact factor: 4.673

5.  Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments.

Authors:  J R Mendell; Z Sahenk; T Gales; L Paul
Journal:  Arch Neurol       Date:  1991-12

6.  Diffuse type of senile plaques in the brains of Alzheimer-type dementia.

Authors:  H Yamaguchi; S Hirai; M Morimatsu; M Shoji; Y Harigaya
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

7.  Immunohistochemical demonstration of proteinase inhibitor alpha-1-antichymotrypsin in normal human central nervous system.

Authors:  D L Justice; R H Rhodes; Z A Tökés
Journal:  J Cell Biochem       Date:  1987-08       Impact factor: 4.429

8.  Inclusion body myositis. Observations in 40 patients.

Authors:  B P Lotz; A G Engel; H Nishino; J C Stevens; W J Litchy
Journal:  Brain       Date:  1989-06       Impact factor: 13.501

9.  Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals.

Authors:  F Tagliavini; G Giaccone; B Frangione; O Bugiani
Journal:  Neurosci Lett       Date:  1988-11-11       Impact factor: 3.046

10.  Light and electron microscopic localization of beta-amyloid protein in muscle biopsies of patients with inclusion-body myositis.

Authors:  V Askanas; W K Engel; R B Alvarez
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

View more
  13 in total

1.  Glucocorticoid-sensitive hereditary inclusion body myositis.

Authors:  M Naumann; H Reichmann; H H Goebel; C Moll; K V Toyka
Journal:  J Neurol       Date:  1996-02       Impact factor: 4.849

Review 2.  Amyotrophic lateral sclerosis: current and future treatment strategies.

Authors:  B W Festoff
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

3.  Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy.

Authors:  V Askanas; W K Engel; C C Yang; R B Alvarez; V M Lee; T Wisniewski
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

4.  Twisted tubulofilaments of inclusion body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau.

Authors:  V Askanas; W K Engel; M Bilak; R B Alvarez; D J Selkoe
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

5.  Conspicuous accumulation of a single-stranded DNA binding protein in skeletal muscle fibers in inclusion body myositis.

Authors:  J Nalbantoglu; G Karpati; S Carpenter
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

6.  Transgenic mice over-expressing the C-99 fragment of betaPP with an alpha-secretase site mutation develop a myopathy similar to human inclusion body myositis.

Authors:  L W Jin; M G Hearn; C E Ogburn; N Dang; D Nochlin; W C Ladiges; G M Martin
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

7.  Amyloid-beta deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy.

Authors:  K Fukuchi; D Pham; M Hart; L Li; J R Lindsey
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

8.  Transfer of beta-amyloid precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle.

Authors:  V Askanas; J McFerrin; S Baqué; R B Alvarez; E Sarkozi; W K Engel
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

Review 9.  Inclusion body myositis: a view from the Caenorhabditis elegans muscle.

Authors:  Daniela L Rebolledo; Alicia N Minniti; Paula M Grez; Ricardo Fadic; Rebecca Kohn; Nibaldo C Inestrosa
Journal:  Mol Neurobiol       Date:  2008-09-05       Impact factor: 5.590

10.  How citation distortions create unfounded authority: analysis of a citation network.

Authors:  Steven A Greenberg
Journal:  BMJ       Date:  2009-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.